National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 51041 [2020-18132]
Download as PDF
Federal Register / Vol. 85, No. 161 / Wednesday, August 19, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Literature Selection
Technical Review Committee, October
22–23, 2020, 8:30 a.m. to 5:00 p.m.,
video assisted meeting, which was
published in the Federal Register on
August 5, 2020, 85 FR 151, Page 47391.
This notice is being amended to
change the meeting dates from October
22–23, 2020 to October 21–22, 2020.
This meeting will be a video assisted
meeting. The videocast link is https://
videocast.nih.gov/.
Dated: August 13, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–18057 Filed 8–18–20; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Preclinical Services for HIV
Therapeutics (Task Area G).
Date: September 2, 2020.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G33,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: David C. Chang, Ph.D.,
Scientific Review Officer, Scientific Review
Program, National Institute of Allergy and
16:34 Aug 18, 2020
Dated: August 13, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–18132 Filed 8–18–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse Treatment
BILLING CODE 4140–01–P
VerDate Sep<11>2014
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G33,
Rockville, MD 20852, (301) 594–4218,
changdac@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Jkt 250001
Notice of Meeting
Notice is hereby given of the meeting
on September 22, 2020 of the Substance
Abuse and Mental Health Services
Administration’s (SAMHSA) Center for
Substance Abuse Treatment (CSAT)
National Advisory Council (NAC).
The meeting is open to the public and
can be accessed remotely via WebEx
and telephone only. It will include
consideration of minutes from the
SAMHSA CSAT NAC meeting of March
26, 2020; an update on CSAT activities;
a discussion on SAMHSA’s Strategic
Plan; a discussion on SAMHSA’s
response to prevent suicide due to the
COVID–19 Pandemic; and a discussion
on the latest findings from the National
Survey on Drug Use and Health
(NSDUH).
Interested persons may present data,
information, or views, orally or in
writing, on issues pending before the
Council. Written submissions should be
forwarded to the contact person on or
before September 15, 2020. Oral
presentations from the public will be
scheduled at the conclusion of the
meeting. Individuals interested in
making oral presentations must notify
the contact person on or before
September 15, 2020. Up to five minutes
will be allotted for each presentation.
Registration is required to participate
during this meeting. To attend virtually,
or to obtain the call-in number and
access code, submit written or brief oral
comments, or request special
accommodations for persons with
disabilities, please register on-line at
https://snacregister.samhsa.gov/
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
51041
MeetingList.aspx, or communicate with
the contact person.
Meeting information and a roster of
Council members may be obtained by
accessing the SAMHSA Committee
website at https://www.samhsa.gov/
about-us/advisory-councils/csatnational-advisory-council or the contact
person.
Council Name: SAMHSA’s Center for
Substance Abuse Treatment National
Advisory Council.
Date/Time/Type: September 22, 2020,
1:00 p.m.–6:00 p.m. EDT, Open.
Place: SAMHSA, 5600 Fishers Lane,
Rockville, Maryland 20857.
Contact: Tracy Goss, Designated
Federal Officer, CSAT National
Advisory Council, 5600 Fishers Lane,
Rockville, Maryland 20857 (mail),
Telephone: (240) 276–0759, Email:
tracy.goss@samhsa.hhs.gov.
Authority: Public Law 92–463
Dated: August 13, 2020.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2020–18117 Filed 8–18–20; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2020–0318]
Gulf of Mexico Area Maritime Security
Advisory Committee (AMSC)
Coast Guard, DHS.
Solicitation for membership.
AGENCY:
ACTION:
This notice requests
individuals interested in serving on the
Gulf of Mexico Area Maritime Security
Advisory Committee (AMSC) submit
their applications for membership to the
Federal Maritime Security Coordinator
(FMSC) Eighth Coast Guard District. The
Committee assists the FMSC, Eighth
District, in developing, reviewing, and
updating the Area Maritime Security
Plan for their area of responsibility.
DATES: Requests for membership should
reach the U.S. Coast Guard FMSC
Eighth Coast Guard District on
September 18, 2020.
ADDRESSES: Applications for
membership should be submitted to the
FMSC at the following address:
Commander, Eighth Coast Guard
District, Attn: Mr. Nick Parham, Gulf
Mexico AMSC Executive Secretary, Hale
Boggs Federal Building, 500 Poydras St.,
Suite 1341, New Orleans, LA 70130.
FOR FURTHER INFORMATION CONTACT: For
questions about submitting an
SUMMARY:
E:\FR\FM\19AUN1.SGM
19AUN1
Agencies
[Federal Register Volume 85, Number 161 (Wednesday, August 19, 2020)]
[Notices]
[Page 51041]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18132]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Preclinical Services for HIV
Therapeutics (Task Area G).
Date: September 2, 2020.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G33,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: David C. Chang, Ph.D., Scientific Review
Officer, Scientific Review Program, National Institute of Allergy
and Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, Room 3G33, Rockville, MD 20852, (301) 594-4218,
[email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 13, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-18132 Filed 8-18-20; 8:45 am]
BILLING CODE 4140-01-P